• Home
  • Search Results
  • de novo design and synthesis of N-benzylanilines as new candidates for VEGFR tyrosine kinase inhibitors.

de novo design and synthesis of N-benzylanilines as new candidates for VEGFR tyrosine kinase inhibitors.

Organic & biomolecular chemistry (2008-03-11)
Masaharu Uno, Hyun Seung Ban, Wataru Nabeyama, Hiroyuki Nakamura
ABSTRACT

N-Benzylanilines were designed and synthesized as vascular endothelial growth factor (VEGF)-2 inhibitors using de novo drug design systems based on the X-ray structure of VEGFR-2 kinase domain. Among compounds synthesized, compound showed the most potent inhibitory activity toward VEGFR-2 (KDR) tyrosine kinase and its IC(50) value was 0.57 microM.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N-Benzylaniline, ≥99%

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.